| Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles HL Wong, R Bendayan, AM Rauth, Y Li, XY Wu Advanced drug delivery reviews 59 (6), 491-504, 2007 | 759 | 2007 |
| Nanotechnological advances for the delivery of CNS therapeutics HL Wong, XY Wu, R Bendayan Advanced drug delivery reviews 64 (7), 686-700, 2012 | 649 | 2012 |
| A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system HL Wong, R Bendayan, AM Rauth, HY Xue, K Babakhanian, XY Wu Journal of Pharmacology and Experimental Therapeutics 317 (3), 1372-1381, 2006 | 441 | 2006 |
| Current approaches to enhance CNS delivery of drugs across the brain barriers CT Lu, YZ Zhao, HL Wong, J Cai, L Peng, XQ Tian International journal of nanomedicine, 2241-2257, 2014 | 401 | 2014 |
| A new polymer–lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells HL Wong, AM Rauth, R Bendayan, JL Manias, M Ramaswamy, Z Liu, ... Pharmaceutical research 23, 1574-1585, 2006 | 385 | 2006 |
| Nanomedicine of synergistic drug combinations for cancer therapy–Strategies and perspectives RX Zhang, HL Wong, HY Xue, JY Eoh, XY Wu Journal of Controlled Release 240, 489-503, 2016 | 354 | 2016 |
| Nanocarrier for poorly water-soluble anticancer drugs—barriers of translation and solutions M Narvekar, HY Xue, JY Eoh, HL Wong Aaps Pharmscitech 15, 822-833, 2014 | 303 | 2014 |
| Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine HY Xue, S Liu, HL Wong Nanomedicine 9 (2), 295-312, 2014 | 272 | 2014 |
| Nanotechnology applications for improved delivery of antiretroviral drugs to the brain HL Wong, N Chattopadhyay, XY Wu, R Bendayan Advanced drug delivery reviews 62 (4-5), 503-517, 2010 | 267 | 2010 |
| Lipid-based nanocarriers for RNA delivery H Yi Xue, P Guo, WC Wen, H Lun Wong Current pharmaceutical design 21 (22), 3140-3147, 2015 | 256 | 2015 |
| Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer HL Wong, R Bendayan, AM Rauth, XY Wu Journal of controlled release 116 (3), 275-284, 2006 | 253 | 2006 |
| Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line N Chattopadhyay, J Zastre, HL Wong, XY Wu, R Bendayan Pharmaceutical research 25, 2262-2271, 2008 | 231 | 2008 |
| Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers HL Wong, R Bendayan, AM Rauth, XY Wu Journal of pharmaceutical sciences 93 (8), 1993-2008, 2004 | 223 | 2004 |
| Nanomedicine applications in the treatment of breast cancer: current state of the art D Wu, M Si, HY Xue, HL Wong International journal of nanomedicine, 5879-5892, 2017 | 191 | 2017 |
| In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model HL Wong, AM Rauth, R Bendayan, XY Wu European journal of pharmaceutics and biopharmaceutics 65 (3), 300-308, 2007 | 147 | 2007 |
| Using NGF heparin-poloxamer thermosensitive hydrogels to enhance the nerve regeneration for spinal cord injury YZ Zhao, X Jiang, J Xiao, Q Lin, WZ Yu, FR Tian, KL Mao, W Yang, ... Acta biomaterialia 29, 71-80, 2016 | 143 | 2016 |
| Molecular interactions, internal structure and drug release kinetics of rationally developed polymer–lipid hybrid nanoparticles Y Li, HL Wong, AJ Shuhendler, AM Rauth, XY Wu Journal of controlled release 128 (1), 60-70, 2008 | 120 | 2008 |
| Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model YZ Zhao, M Lin, Q Lin, W Yang, XC Yu, FR Tian, KL Mao, JJ Yang, CT Lu, ... Journal of controlled release 224, 165-175, 2016 | 106 | 2016 |
| Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization HY Xue, HL Wong Biomaterials 32 (10), 2662-2672, 2011 | 105 | 2011 |
| Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery YZ Zhao, Q Lin, HL Wong, XT Shen, W Yang, HL Xu, KL Mao, FR Tian, ... Journal of controlled release 224, 112-125, 2016 | 93 | 2016 |
